This country profile provides an overview of Angola’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Priorities for progress in Angola
- Angola is commended for taking positive steps to improve the coverage of intestinal worms, by securing a grant from the World Bank Trust Fund and for the development of a national health strategy for NTDs.
- As a next step, Angola should work to fully integrate the treatment of NTDs, including elephantiasis and river blindness, whilst increasing coverage across the board.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Treatment coverage slightly increased from 1% in 2016 to 2% in 2017.
Angola does not require mass treatment for blinding trachoma.
Treatment coverage decreased from 27% in 2016 to 25% in 2017.
Treatment coverage decreased from 50% in 2016 to 45% in 2017.
Treatment coverage slightly increased from 2% in 2016 to 4% in 2017.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Angola.